NASDAQ
Enlivex Ltd. - Ordinary Shares (ENLV)
♥ 610 Thanks from members
Enlivex Ltd. (ENLV) presents a volatile risk-reward profile, balancing clinical-stage immunotherapy development for Allocetra™ with a novel crypto-treasury strategy anchored by the Rain protocol, alongside acute Nasdaq compliance risks.